C166H184Cl2N24O12 — CID 159288507
4-(6-acetamido-1H-benzimidazol-2-yl)-N-(2-methylcyclohexyl)benzamide;4-(6-benzamido-1H-benzimidazol-2-yl)-N-(2-methylcyclohexyl)benzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-(4-methylcyclohexyl)benzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-(2-methylcyclohexyl)benzamide;3,4-dichloro-N-[2-[4-[(2-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]benzamide;N-[2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide (PubChem CID 159288507) has the molecular formula C166H184Cl2N24O12 and a molecular weight of 2778.36 g/mol. Its IUPAC name is 4-(6-acetamido-1H-benzimidazol-2-yl)-N-(2-methylcyclohexyl)benzamide;4-(6-benzamido-1H-benzimidazol-2-yl)-N-(2-methylcyclohexyl)benzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-(4-methylcyclohexyl)benzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-(2-methylcyclohexyl)benzamide;3,4-dichloro-N-[2-[4-[(2-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]benzamide;N-[2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide.
| Compound Name | 4-(6-acetamido-1H-benzimidazol-2-yl)-N-(2-methylcyclohexyl)benzamide;4-(6-benzamido-1H-benzimidazol-2-yl)-N-(2-methylcyclohexyl)benzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-(4-methylcyclohexyl)benzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-(2-methylcyclohexyl)benzamide;3,4-dichloro-N-[2-[4-[(2-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]benzamide;N-[2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide |
|---|---|
| PubChem CID | 159288507 |
| Molecular Formula | C166H184Cl2N24O12 |
| Molecular Weight | 2778.36 g/mol |
| Exact Mass | 2775.39 |
| IUPAC Name | 4-(6-acetamido-1H-benzimidazol-2-yl)-N-(2-methylcyclohexyl)benzamide;4-(6-benzamido-1H-benzimidazol-2-yl)-N-(2-methylcyclohexyl)benzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-(4-methylcyclohexyl)benzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-(2-methylcyclohexyl)benzamide;3,4-dichloro-N-[2-[4-[(2-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]benzamide;N-[2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide |
| SMILES | CC(=O)Nc1ccc2nc(-c3ccc(C(=O)NC4CCCCC4C)cc3)[nH]c2c1.CC1CCC(NC(=O)c2ccc(-c3nc4ccc(NC(=O)C56CC7CC(CC(C7)C5)C6)cc4[nH]3)cc2)CC1.CC1CCC(NC(=O)c2ccc(-c3nc4ccc(NC(=O)C5CCCCC5)cc4[nH]3)cc2)CC1.CC1CCCCC1NC(=O)c1ccc(-c2nc3ccc(NC(=O)C4CCCC4)cc3[nH]2)cc1.CC1CCCCC1NC(=O)c1ccc(-c2nc3ccc(NC(=O)c4ccc(Cl)c(Cl)c4)cc3[nH]2)cc1.CC1CCCCC1NC(=O)c1ccc(-c2nc3ccc(NC(=O)c4ccccc4)cc3[nH]2)cc1 |
| InChI | InChI=1S/C32H38N4O2.C28H26Cl2N4O2.C28H28N4O2.C28H34N4O2.C27H32N4O2.C23H26N4O2/c1-19-2-8-25(9-3-19)33-30(37)24-6-4-23(5-7-24)29-35-27-11-10-26(15-28(27)36-29)34-31(38)32-16-20-12-21(17-32)14-22(13-20)18-32;1-16-4-2-3-5-23(16)34-27(35)18-8-6-17(7-9-18)26-32-24-13-11-20(15-25(24)33-26)31-28(36)19-10-12-21(29)22(30)14-19;1-18-7-5-6-10-23(18)32-28(34)21-13-11-19(12-14-21)26-30-24-16-15-22(17-25(24)31-26)29-27(33)20-8-3-2-4-9-20;1-18-7-13-22(14-8-18)29-28(34)21-11-9-19(10-12-21)26-31-24-16-15-23(17-25(24)32-26)30-27(33)20-5-3-2-4-6-20;1-17-6-2-5-9-22(17)31-27(33)20-12-10-18(11-13-20)25-29-23-15-14-21(16-24(23)30-25)28-26(32)19-7-3-4-8-19;1-14-5-3-4-6-19(14)27-23(29)17-9-7-16(8-10-17)22-25-20-12-11-18(24-15(2)28)13-21(20)26-22/h4-7,10-11,15,19-22,25H,2-3,8-9,12-14,16-18H2,1H3,(H,33,37)(H,34,38)(H,35,36);6-16,23H,2-5H2,1H3,(H,31,36)(H,32,33)(H,34,35);2-4,8-9,11-18,23H,5-7,10H2,1H3,(H,29,33)(H,30,31)(H,32,34);9-12,15-18,20,22H,2-8,13-14H2,1H3,(H,29,34)(H,30,33)(H,31,32);10-17,19,22H,2-9H2,1H3,(H,28,32)(H,29,30)(H,31,33);7-14,19H,3-6H2,1-2H3,(H,24,28)(H,25,26)(H,27,29) |
| InChIKey | KZUVATNHZIUKJO-UHFFFAOYSA-N |
| XLogP | 35.80 |
| TPSA | 521.28 Ų |
| H-Bond Donors | 18 |
| H-Bond Acceptors | 18 |
| Rotatable Bonds | 29 |
| Heavy Atoms | 204 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2778.36 |
| LogP ≤ 5 | 35.80 |
| H-Bond Donors ≤ 5 | 18 |
| H-Bond Acceptors ≤ 10 | 18 |